Soleno Therapeutics (SLNO) Other financing activities: 2014-2018
Historic Other financing activities for Soleno Therapeutics (SLNO) over the last 1 years, with Sep 2018 value amounting to $700,000.
- Soleno Therapeutics' Other financing activities was N/A to $700,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $1.8 million, marking a year-over-year change of. This contributed to the annual value of $16,000 for FY2022, which is 86.67% down from last year.
- As of Q3 2018, Soleno Therapeutics' Other financing activities stood at $700,000, which was up 64.71% from $425,000 recorded in Q2 2018.
- In the past 5 years, Soleno Therapeutics' Other financing activities registered a high of $1.8 million during Q4 2014, and its lowest value of -$71,000 during Q2 2016.
- For the 3-year period, Soleno Therapeutics' Other financing activities averaged around $291,667, with its median value being $312,500 (2017).
- Data for Soleno Therapeutics' Other financing activities shows a maximum YoY tumbled of 97.55% (in 2015) over the last 5 years.
- Quarterly analysis of 5 years shows Soleno Therapeutics' Other financing activities stood at $1.8 million in 2014, then slumped by 97.55% to $45,181 in 2015, then tumbled by 86.60% to -$71,000 in 2016, then reached $225,000 in 2017, then reached $700,000 in 2018.
- Its Other financing activities was $700,000 in Q3 2018, compared to $425,000 in Q2 2018 and $400,000 in Q1 2018.